• Exchange: -
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Cosmo Pharmaceuticals SpA

CQ1:GR

Ticker Delisted

Snapshot for Cosmo Pharmaceuticals SpA (CQ1)

Open: - Day's Range: - Volume: 0
Previous Close: - 52wk Range: - 1-Yr Rtn: -

Stock Chart for CQ1

No chart data available.
  • CQ1:GR
  • 1M
  • 1Y
0.000
Interactive CQ1 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for CQ1

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 12.1771
Relative P/E vs. DAX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2014) 2.7100
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 03/25/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for CQ1

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for CQ1

Cosmo Pharmaceuticals SpA develops and manufactures therapies for gastrointestinal diseases. The Company's proprietary technology delays the delivery of the active drug mainly into the lumen of the colon. Cosmo develops treatments for inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and for colon infections.

Mauro Severino AjaniChairman/FounderAlessandro Della ChaChief Executive Officer
Hans Christoph TannerChief Financial OfficerMarco LecchiDeputy Chief Financial Officer
More Company Profile & Key Executives for CQ1

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil